dc.contributor.author | Bird, S | |
dc.contributor.author | Panopoulou, A | |
dc.contributor.author | Shea, RL | |
dc.contributor.author | Tsui, M | |
dc.contributor.author | Saso, R | |
dc.contributor.author | Sud, A | |
dc.contributor.author | West, S | |
dc.contributor.author | Smith, K | |
dc.contributor.author | Barwood, J | |
dc.contributor.author | Kaczmarek, E | |
dc.contributor.author | Panlaqui, C | |
dc.contributor.author | Kaiser, M | |
dc.contributor.author | Stern, S | |
dc.contributor.author | Pawlyn, C | |
dc.contributor.author | Boyd, K | |
dc.date.accessioned | 2021-05-11T11:07:52Z | |
dc.date.available | 2021-05-11T11:07:52Z | |
dc.date.issued | 2021-05-25 | |
dc.identifier.citation | The Lancet. Haematology, 2021 | |
dc.identifier.issn | 2352-3026 | |
dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/4548 | |
dc.identifier.eissn | 2352-3026 | |
dc.identifier.doi | 10.1016/s2352-3026(21)00110-1 | |
dc.format | Print-Electronic | |
dc.language | eng | |
dc.language.iso | eng | |
dc.publisher | ELSEVIER SCI LTD | |
dc.rights.uri | https://www.rioxx.net/licenses/all-rights-reserved | |
dc.title | Response to first vaccination against SARS-CoV-2 in patients with multiple myeloma. | |
dc.type | Journal Article | |
dcterms.dateAccepted | 2021-04-19 | |
rioxxterms.version | VoR | |
rioxxterms.versionofrecord | 10.1016/s2352-3026(21)00110-1 | |
rioxxterms.licenseref.uri | https://www.rioxx.net/licenses/all-rights-reserved | |
rioxxterms.licenseref.startdate | 2021-04-19 | |
rioxxterms.type | Journal Article/Review | |
dc.relation.isPartOf | The Lancet. Haematology | |
pubs.notes | Not known | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Genetics and Epidemiology | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Genetics and Epidemiology/Cancer Genomics | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology/Myeloma Group | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Genetics and Epidemiology | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Genetics and Epidemiology/Cancer Genomics | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology/Myeloma Group | |
pubs.publication-status | Published | |
pubs.embargo.terms | Not known | |
icr.researchteam | Cancer Genomics | |
icr.researchteam | Myeloma Group | |
icr.researchteam | Cancer Genomics | |
icr.researchteam | Myeloma Group | |
dc.contributor.icrauthor | Panopoulou, Aikaterini | |
dc.contributor.icrauthor | Sud, Amit | |
dc.contributor.icrauthor | Kaiser, Martin | |
dc.contributor.icrauthor | Pawlyn, Charlotte | |